Back to Search
Start Over
Sodium–glucose cotransporter 2 inhibitor‐associated diabetic ketoacidosis in patients with type 1 diabetes: Metabolic imbalance as an underlying mechanism
- Source :
- Journal of Diabetes Investigation, Vol 10, Iss 4, Pp 879-882 (2019), Journal of Diabetes Investigation
- Publication Year :
- 2019
- Publisher :
- Wiley, 2019.
-
Abstract
- For type 1 diabetes patients with inadequate glycemic control, one treatment option is to increase the insulin dose (scenario 1), which should not give rise to a "metabolic imbalance." A second option is additional treatment with a sodium-glucose cotransporter 2 inhibitor, which might lead to a "metabolic imbalance" (scenario 2). A reduction in insulin dose in addition to administration of a sodium-glucose cotransporter 2 inhibitor might further increase the "metabolic imbalance" (scenario 3).
- Subjects :
- medicine.medical_specialty
Diabetic ketoacidosis
Endocrinology, Diabetes and Metabolism
030209 endocrinology & metabolism
030204 cardiovascular system & hematology
Diseases of the endocrine glands. Clinical endocrinology
Diabetic Ketoacidosis
03 medical and health sciences
0302 clinical medicine
Diabetes mellitus
Internal medicine
Internal Medicine
Medicine
Humans
In patient
Sodium-Glucose Cotransporter 2 Inhibitor
Sodium-Glucose Transporter 2 Inhibitors
Glycemic
Type 1 diabetes
business.industry
Mechanism (biology)
Incidence
General Medicine
medicine.disease
Prognosis
RC648-665
Endocrinology
Editorial
Diabetes Mellitus, Type 1
business
Cotransporter
Subjects
Details
- Language :
- English
- ISSN :
- 20401116 and 20401124
- Volume :
- 10
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Journal of Diabetes Investigation
- Accession number :
- edsair.doi.dedup.....ca9dc4c9a361ba5973389d465e4f59c2